What Is Wet Macular Degeneration?

Table of Contents
View All
Table of Contents

Worldwide, age-related macular degeneration (AMD) is the leading cause of severe vision loss in people aged 50 or older. Neovascular AMD is an advanced form of the condition, also known as “exudative AMD" or “wet macular degeneration.” The wet form is less common than the dry form of AMD, occurring in roughly 10–15% of people who have AMD. The risk of AMD increases significantly in people over the age of 80.

wet macular degeneration
Hilary Alison / Verywell


Typically wet AMD results in severe vision loss. These symptoms may come on suddenly and worsen quickly, even though the underlying problem has been developing over a long period of time. Wet AMD might affect only one of your eyes or both.

Wet AMD affects the central part of your visual field, not the peripheral areas. Because of this, only rarely does it cause total blindness. The central area of your visual field might have a blind spot, or this area might become very blurry.

Some other specific symptoms might include:

  • Decreased color brightness
  • Visual distortions (e.g., a straight object appearing to bend)
  • General haziness of vision

Dry and wet AMD typically affect both eyes, though symptoms can begin in one before the other.

The condition can profoundly affect quality of life. Because of vision loss, you might not be able to drive, enjoy certain activities, or read.

People who have wet AMD can also experience other problems resulting from these vision issues. For example, people might become depressed and socially withdrawn because they are having trouble with tasks they once performed easily.


To understand what causes wet AMD, it’s helpful to understand a little about your eye. Your macula is part of your retina that is located at the back part of your eye. It helps provide the sharp vision that you have in the center of your visual field when looking straight ahead.

The macula has many light-sensing cells that send electrical signals via the optic nerve to the brain. This process puts together the images that we see.

The layer of the eye just behind the retina is called the choroid. It normally has blood vessels that bring blood to the light cells of the retina, including the macula. Wet AMD develops as blood vessels from the choroid start to invade the retina and grow abnormally there. These fragile vessels may start to leak, which can interfere with the normal function of the macula. That’s why this type of AMD is called “wet” AMD.

The abnormal blood vessel growth found in wet AMD is partially caused by the presence of VEGF (vascular endothelial growth factor), a signaling molecule. This may be found at higher than normal levels in people with wet AMD.

Environmental and Genetic Factors

AMD (and wet AMD specifically) are probably caused by a combination of environmental and genetic factors that are still not completely understood.

Some of the factors thought to increase one’s risk of getting AMD are:

  • History of smoking
  • Family history of AMD
  • Previous cataract surgery
  • Cardiovascular risk factors (such as known atherosclerosis, high cholesterol, or high blood pressure)
  • White racial background


Wet macular degeneration is a specific subtype of age-related macular degeneration. In the dry version of AMD, there aren’t the same kinds of abnormal blood vessels beneath the eye. However, there may be other problems causing more gradual damage to the light-sensing cells of the macula.

People with AMD also have something called drusen, which are yellow deposits found beneath the retina. Though drusen are a normal part of aging, large or medium drusen are often a sign of AMD.

Dry AMD might be early, intermediate, or advanced. People with early or intermediate disease might not notice any symptoms. In contrast, the wet form of AMD is always an advanced form of the disease.

Wet AMD always starts out as the dry version of AMD. That’s one of the reasons it’s important to monitor early forms of AMD for progression to later kinds.


To diagnose wet AMD, your clinician will ask you about your symptoms and your medical history. This will include information about your vision, how rapidly the symptoms are progressing, whether the symptoms come and go, your other medical conditions, and your family history.

You will also need a comprehensive eye exam, which will include having your eyes dilated with drops. Your clinician will also be able to detect other eye issues if you have them, like eye complications from diabetes, glaucoma, and cataracts.

Portions of the eye exam might include the following:

  • Basic tests of visual acuity
  • Examination of the back of your eye
  • Examination using an Amsler grid (pattern of gridded lines that may appear missing or distorted in someone with AMD)

If you have early or intermediate AMD, your healthcare provider might give you an Amsler grid to take home, so you will be able to notice early signs that your vision might be worsening.

Other Eye Tests

If your eye examination suggests that you might have wet AMD, you will probably need more advanced tests to confirm the diagnosis. These tests may also be used to assess your response to treatment.

  • Fluorescein angiogram: A fluorescent dye is injected into your arm by an ophthalmologist. Pictures can be taken as the dye passes through the blood vessels of the eye. The pictures would show any leaky abnormal blood vessels of wet AMD.
  • Optical coherence tomography: This painless and non-invasive test uses light waves to get an image of the back of the eye.

Depending on the situation, additional tests may be needed, as well.

It’s important to seek medical attention and get a proper diagnosis as soon as possible after your symptoms start. If your diagnosis and treatment are delayed, it may become difficult—or impossible—to reverse your symptoms.


In recent years, treatments have become available that may help slow vision loss from wet AMD. However, in some cases, the disease may worsen even when you receive proper treatment.

Injections of VEGF drugs

A group of drugs known as anti-VEGF agents are the first treatments used for wet AMD. Since they were approved in 2006, they have revolutionized the treatment for wet AMD. In some cases, these injections help the person to at least partly improve their vision.

By blocking the signaling of the VEGF molecules, these drugs inhibit the excess formation of new blood vessels in the eye.

These drugs are injected into the eye, sometimes scheduled multiple times a month. Before having an injection, your eye would be numbed and cleaned with an antiseptic drop. After injections, you may need to take antibiotic eye drops and injections may be less frequent after the initial treatment.

Some of the anti-VEGF drugs prescribed for wet AMD include:

  • Macugen (pegaptanib)
  • Lucentis (ranibizumab)
  • Avastin (bevacizumab)
  • Eylea (aflibercept)
  • Beovu (brolicizumab)

Anti-VEGF drugs vary in their cost and in the frequency of needed injections, so it’s worth discussing your options with your healthcare provider.

Photodynamic Therapy and Laser Photocoagulation Surgery

Your healthcare provider may suggest these options if you are still having issues after trying anti-VEGF therapies. They also may be an option if you have wet AMD with particular anatomical characteristics. They are sometimes used along with anti-VEGF drugs.

  • In photodynamic therapy, you are injected with a drug called verteporfin. The clinician activates the drug as it travels through the abnormal vessels by shining a laser beam into your eye. This activates the drug to close off these new blood vessels. This potentially slows vision loss.
  • Laser photocoagulation surgery is a less common option. It's a type of minimally invasive surgery for the eyes that can be used to seal or destroy leaky blood vessels.

Nutritional Supplements

Some evidence shows that certain nutritional supplements may help slow vision loss in people who have wet AMD, though it will not restore vision that's already lost. It also might help prevent the development of wet AMD in your other eye.

In clinical trials, the combination of nutrients and antioxidants found to be helpful were:

  • Vitamin C (500 milligrams)
  • Vitamin E (400 International units)
  • Zinc (80 milligrams zinc oxide)
  • Copper (2 milligrams cupric oxide)
  • Lutein (10 milligrams)
  • Zeaxanthin (2 milligrams)

You might benefit from taking additional supplements, even if you already take a multivitamin because not all multivitamins will contain all these nutrients. Talk to your healthcare provider about the best product for you to take.

Lifestyle Modifications

Practicing a healthy lifestyle is also an important part of treatment and prevention. By regularly exercising, eating a healthy diet, and not smoking, you may help slow the progression of your disease.


Some people find it very hard to cope with AMD, especially if treatment is unable to restore their vision loss. Understandably, it can be a real psychological and physical challenge to cope if you are having problems performing your everyday tasks. Many people report depression and reduced quality of life from these visual changes. You may need to go through a grief process before you can accept your life and move forward.

While it’s normal to feel these things, know that you have resources to support you. There are a number of professionals that can help you as you adjust to life with diminished vision. These may include occupational therapists, mobility specialists, and low vision therapists. Depending on the situation, social workers or counselors may be able to help, as well. These professionals can provide a wide range of products, services, and education that can help you adapt to your new situation.

A Word From Verywell

It can be a shock to learn that you have a serious medical problem like wet age-related macular degeneration. Realistically, the condition is likely to disrupt your everyday life, at least for a while. Fortunately, there are now treatment options that may be able to help restore your vision and health professionals who can help you make the most of your situation. Learning what you can about your treatment options can help give you a sense of control. 

9 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. U.S. National Library of Medicine. Age-related macular degeneration.

  2. Chong V. Ranibizumab for the treatment of wet AMD: a summary of real-world studies. Eye (Lond). 2016;30(2):270-86. doi:10.1038/eye.2015.217

  3. Al-zamil WM, Yassin SA. Recent developments in age-related macular degeneration: a review. Clin Interv Aging. 2017;12:1313-1330. doi:10.2147/CIA.S143508

  4. Waugh N, Loveman E, Colquitt J, et al. Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review. NIHR Journals Library.

  5. Pelletier AL, Rojas-Roldan L, Coffin J. Vision loss in older adults. Am Fam Physician. 2016;94(3):219-26.

  6. American Academy of Ophthalmology. What is fluorescein angiography?

  7. Supuran CT. Agents for the prevention and treatment of age-related macular degeneration and macular edema: a literature and patent review. Expert Opin Ther Pat. 2019;29(10):761-767. doi:10.1080/13543776.2019.1671353

  8. Reeves BC, Harding SP, Langham J, et al. Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK. Health Technol Assess. 2012;16(6):i-xii, 1-200. doi:10.3310/hta16060

  9. American Optometric Association. Nutrition and AMD.

By Ruth Jessen Hickman, MD
Ruth Jessen Hickman, MD, is a freelance medical and health writer and published book author.